OmniAb Investor Conference Presentation Deck slide image

OmniAb Investor Conference Presentation Deck

OmniAb's History BEST-IN-CLASS PLATFORM BUILT FROM~15 YEARS OF INVESTMENT AND STRATEGIC ACQUISITIONS 2008 OMT Founded Development of OmniRat/OmniFlic/OmniMouse & 16 partnerships signed Acquired OMT (OmniRat, OmniMouse) ● 2016 ● ● 2017 Acquired Crystal BioScience (OmniChicken) 2018 Acquired Ab Initio (Computationally-Powered Antigen Design) Internal Investment and R&D Next-generation animals (Bispecifics, Heavy-Chain, etc.) Expanded state-of-the-art labs and facilities and added capacity Al-powered single-cell microcapillary platform expansion 2019 Acquired Icagen (lon Channel Technology) Strategically built tech platform to optimally harness the power of Biological Intelligence™ 19 2020 Acquired Taurus (OmniTaur) Acquired xCella Biosciences (Microcapillary Screening Platform) OmniAb
View entire presentation